Humacyte announced positive interim results from its Phase 3 V012 trial showing that the acellular tissue engineered vessel (ATEV) significantly improves hemodialysis access for women with end-stage kidney disease. Women receiving the ATEV achieved functional access 3.6 months faster and spent 91 more catheter-free days in the first year compared to those with the standard arteriovenous fistula (AV fistula). The trial met its primary endpoint, leading to early enrollment stop, and showed fewer infections with ATEV. These findings suggest ATEV could become a preferred option for female hemodialysis patients once FDA approved, addressing historically poorer outcomes with AV fistulas in women.
Humacyte's Phase 3 trial results for a new hemodialysis access device provide context for health sector investors. As of Oct 23, 2026 18:41 WIB, 31 of 150 health-sector US stocks on Pluang rose while 112 fell. Notable prices include Bruker Corporation at USD 56.00 with a -2.29% change and Dyne Therapeutics at USD 15.52, experiencing 100% sell order activity and a typical hold time of 4 days.
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
The global computed tomography (CT) market is undergoing significant innovation driven by photon-counting technology, AI integration, mobile imaging, and point-of-care applications. These advancements are enhancing image quality, workflow efficiency,...
